Unichem Laboratories Ltd on Tuesday said it has received an approval from the US health regulator to market its generic version of labetalol hydrochloride tablets used to treat
Share this article
If you liked this article share it with your friends.they will thank you later
/newsdrum-in/media/post_banners/dgBAUOFORlOJYuME6fqQ.jpg)
1 Min read
/newsdrum-in/media/agency_attachments/2025/01/29/2025-01-29t072616888z-nd_logo_white-200-niraj-sharma.jpg){kind=logo}
